Latest filing published 15 Mar 2023 for AtriCure, Inc., €87k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Mark A. Collar (board member) discloses dealings in 2 companies, chiefly AtriCure, Inc. and First Financial Bancorp /OH/. Between 6 January 2016 and 13 March 2023, the trades on record add up to 8 filings.
Both buying and selling appear: 1 purchase, against 2 sales worth €480k. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants and 3 option exercises.
The latest filing, published on 15 March 2023, reports an option exercise of €87k in AtriCure, Inc. The most recent open-market purchase was published on 7 January 2016, 3,937 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations